Collins Cynthia 4

What Happened Cynthia Collins, a director of MaxCyte, received two equity awards on June 17, 2026: 30,421 restricted stock units (RSUs) and 49,579 RSUs (reported as a derivative award). Both awards were granted at $0.00 (typical for RSU grants) for a total of 80,000 RSUs. These RSUs are contingent rights to receive one share of MaxCyte common stock and will vest on June 17, 2027, subject to Collins’ continuous service through the vesting date. This is an award (compensation), not a purchase or sale.

Key Details

• Transaction date: 2026-06-17; Filing date: 2026-06-22.
• Awards: 30,421 RSUs + 49,579 RSUs = 80,000 RSUs; reported price $0.00.
• Vesting: Shares underlying the grant vest on June 17, 2027, subject to continuous service.
• Footnotes: F1 clarifies each RSU is a contingent right to one share; F2 states this is an annual grant under the issuer’s Equity Grant Policy for non‑employee directors.
• Shares owned after transaction: not specified in the provided filing.

Context RSUs are compensation-based awards that convert into actual shares only after vesting; they do not represent immediate share ownership or cash proceeds. Grants to non-employee directors are a routine part of board compensation and are typically intended for retention and alignment with shareholders. The filing shows an award (code A) rather than a market purchase or sale.